射干麻黄汤加减治疗急性支气管炎合并支原体属感染临床研究

发布时间：2018-06-09 00:42

本文选题：急性支气管炎 + 支原体属　；参考：《中华医院感染学杂志》2014年04期

【摘要】：目的探讨射干麻黄汤加减治疗急性支气管炎合并支原体属感染患者的临床效果。方法选取2010年1月-2011年1月收治的92例急性支气管炎合并支原体属感染患者,随机分为对照组及试验组,每组各46例,对照组实施西药治疗,试验组使用射干麻黄汤加减治疗,对比两组治疗效果及不良反应,对结果采用SPSS 13.0统计软件进行分析。结果治疗显效率试验组为56.52%,对照组为39.13%,总有效率试验组为91.80%,对照组为71.74%,两组比较差异均有统计学意义(P0.05);两组患者均出现胃肠反应、静脉刺激、皮疹等不良反应,不良反应发生率试验组为6.52%,对照组为32.61%,差异有统计学意义(P0.05)。结论针对急性支气管炎合并支原体属感染患者使用射干麻黄汤加减治疗临床效果显著确切,安全性高,值得临床推广应用。
[Abstract]:Objective to investigate the clinical effect of Sheganmahuang decoction on acute bronchitis with mycoplasma infection. Methods from January 2010 to January 2011, 92 patients with acute bronchitis complicated with mycoplasma infection were randomly divided into control group and experimental group with 46 cases in each group. The control group was treated with western medicine, and the experimental group was treated with Sheganmahuang decoction. The results were analyzed by SPSS 13.0 software. Results the effective rate of treatment was 56.52 in the experimental group, 39.13 in the control group, 91.80 in the experimental group and 71.74g in the control group. The difference between the two groups was statistically significant (P 0.05). The incidence of adverse reactions was 6.52 in the trial group and 32.61 in the control group. The difference was statistically significant (P 0.05). Conclusion the therapeutic effect of Sheganmahuang decoction on acute bronchitis complicated with mycoplasma infection is significant and safe, which is worth popularizing.
【作者单位】：衢州市第三医院康复科;杭州市中医院呼吸科;衢州市第三医院心身科;
【基金】：浙江省卫生厅科技计划基金(2013KYB217)
【分类号】：R562.21

【相似文献】